BMO Resumes Coverage On Tricon Residential After US IPO

Earlier this month, Tricon Residential (TSX: TCN) announced that they closed their U.S. IPO selling 46,248,746 shares for total proceeds of US$570 million, and completed their listing on the NYSE under the ticker “TCN”. Additionally, Tricon offered a private placement of shares to Blackstone Real Estate Investment Trust.

After the news, many analysts raised their 12-month price targets. The new 12-month price target sits at C$17.38. There are 8 analysts covering the stock with 2 having strong buy ratings and the other 6 have buys. The street high sits at C$19 from BMO Capital Markets while the lowest comes in at C$15.25.

BMO Capital Markets resumed their coverage with an outperform rating on Tricon Residential after the IPO and raised their 12-month price target to C$19 from C$18. They write, “We believe Tricon has a multi-year opportunity for FFO and BVPS growth while leveraging third-party fee-bearing equity capital and reducing leverage.”

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

BMO says that the net proceeds will be used to repay the amount outstanding under its pass-through certificates and the leftover money will be used to purchase future SFR JV-2 homes.

Below you can see BMO’s updated 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A $2.2B Gold Project Is Outgrowing Its Plan | Michael Henrichsen – Gold X2 Mining

Pay for the Copper, Get the Gold Free | Rob McEwen – McEwen Inc

This Gold Discovery Was Already Huge. Now It’s Becoming a Monster. | Goliath Resources

Recommended

Rackla Metals Adds Two Northern Development Veterans to Board as Lentung Advances

Northmin Hits 12.85% Copper and 933 g/t Silver in Highest Grade Tynagh Assays Yet

Related News

Cantor Slashes Hexo Corp’s Price Target After Poorly Priced Financing

Hexo Corp (TSX: HEXO) (NYSE: HEXO) on August 20 announced a $140 million public offering...

Wednesday, August 25, 2021, 10:44:00 AM

Medipharm Labs Receives Price Target Reduction From Canaccord To $1.75

Yesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported...

Tuesday, November 17, 2020, 03:37:00 PM

Canaccord Lifts Xebec Adsorption’s Price Target To $5.00

On November 11th, Xebec Adsorption (TSX: XBC) announced its third quarter financial results. The company...

Sunday, November 21, 2021, 01:22:00 PM

K92 Mining Sees Analysts Reiterate Ratings Following Drill Results

Last week, K92 Mining Inc. (TSX: KNT) reported their Judd Vein System drill results, which...

Sunday, September 5, 2021, 04:50:00 PM

Cresco Labs: Analysts Raise Targets Following Blowout Quarter

On November 18th, Cresco Labs (CSE: CL) reported their third quarter financial results. The company...

Friday, November 20, 2020, 12:09:00 PM